Press-release for stocks for EBS

symbols : EBS

save search

Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
Published: 2024-02-21 (Crawled : 12:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| 34.21% | O: 11.84% H: 91.18% C: 59.41%
ceo

Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with Public Health Agency of Canada
Published: 2022-06-24 (Crawled : 14:20) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -93.38% | O: 6.55% H: 0.91% C: -0.27%
CMRX | $0.8844 -5.14% -5.42% 430K

Health Technology

| -51.65% | O: 2.2% H: 32.8% C: 10.75%
tembexa canada health agreement

Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox
Published: 2022-08-29 (Crawled : 15:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -92.04% | O: -2.07% H: 2.67% C: -1.91%
CMRX | $0.8844 -5.14% -5.42% 430K

Health Technology

| -59.26% | O: -0.93% H: 25.23% C: 8.88%
smallpox tembexa contract

Soligenix Announces Recent Accomplishments And Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 13:00) - prnewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -84.12% | O: 4.98% H: 14.08% C: 11.19%
SNGX | $0.4233 -2.76% -2.83% 1M

Health Technology

| -95.71% | O: 1.67% H: 2.21% C: -1.47%
financial results

Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola
Published: 2023-07-31 (Crawled : 20:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -70.35% | O: 6.83% H: 11.7% C: 7.62%
ebola contract treatment

Emergent BioSolutions is to Participate in Investor Conferences
Published: 2022-01-03 (Crawled : 13:30) - biospace.com/
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -95.31% | O: 0.74% H: 10.09% C: 9.55%
conference merge

Vaxart Provides Business Update and Reports Second Quarter 2021 Financial Results
Published: 2021-08-05 (Crawled : 20:00) - prnewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -96.69% | O: -0.45% H: 1.78% C: -0.75%
VXRT | News | $0.7652 -9.15% -10.08% 1.9M

Health Technology

| -91.25% | O: -3.91% H: 9.7% C: 4.79%
financial results results

Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing
Published: 2023-11-24 (Crawled : 12:30) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -2.39% | O: -4.31% H: 9.0% C: 4.5%

Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency
Published: 2023-08-30 (Crawled : 10:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -49.88% | O: 3.93% H: 8.75% C: 7.33%
narcan opioid life save spray

Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -15.35% | O: 0.83% H: 8.44% C: 4.53%

Emergent BioSolutions Awarded $379.6 Million Procurement Contract to Supply RSDL© (Reactive Skin Decontamination Lotion Kit) to U.S. Department of Defense
Published: 2023-01-05 (Crawled : 23:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -83.48% | O: 3.72% H: 8.04% C: 5.85%
defense contract skin

Top 12 Biotech Companies Hiring Now
Published: 2021-05-11 (Crawled : 15:00) - biospace.com/
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -96.59% | O: -7.83% H: 7.83% C: 6.56%
biotech iot

UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 8, 2023
Published: 2023-10-30 (Crawled : 21:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| 0.49% | O: -0.99% H: 7.46% C: 3.98%
conference financial results

Emergent BioSolutions Announces Sale of Travel Health Business to Bavarian Nordic for Up To $380 Million
Published: 2023-02-15 (Crawled : 09:00) - biospace.com/
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -84.62% | O: 5.58% H: 6.75% C: 6.57%
travel health

Emergent BioSolutions Finalizes Sale of Travel Health Business to Bavarian Nordic
Published: 2023-05-15 (Crawled : 12:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -77.78% | O: -0.98% H: 6.6% C: 2.2%
business health travel

Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
Published: 2024-03-06 (Crawled : 22:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -37.42% | O: -16.26% H: 6.59% C: 1.47%
financial results

Emergent BioSolutions Reports Third Quarter 2023 Financial Results
Published: 2023-11-08 (Crawled : 23:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -7.69% | O: -4.07% H: 6.13% C: 1.42%
financial results

Vaxart Reports First Quarter 2021 Financial Results and Provides Business Update
Published: 2021-05-03 (Crawled : 13:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -96.65% | O: 0.61% H: 0.96% C: 0.39%
VXRT | News | $0.7652 -9.15% -10.08% 1.9M

Health Technology

| -92.95% | O: -7.51% H: 5.92% C: -19.56%
financial results results

Emergent BioSolutions to Release Second Quarter 2021 Financial Results and Conduct a Conference Call on July 29, 2021
Published: 2021-07-15 (Crawled : 11:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -96.52% | O: -0.94% H: 4.82% C: 4.12%
financial results results merge conference

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
Published: 2021-07-19 (Crawled : 12:00) - prnewswire.com
MS | News | $90.66 0.44% 0.07% 8.1M

Finance